Hyphen Pharma - SAC Capital 2023-05-25: Beyond The Shores

Hyphen Pharma - Beyond The Shores

Hyphens Pharma (SGX:1J5) | SGinvestors.ioHyphens Pharma (SGX:1J5)
  • Hyphens Pharma (SGX:1J5), established in 1998, is Singapore’s leading specialty pharmaceutical and consumer healthcare group with a diverse footprint in ASEAN countries.
  • Hyphens Pharma holds exclusive licenses and main distributorship with top pharmaceutical companies globally, mainly from Europe and the United States. They also build a strong franchise by means of in-licensing and R&D collaborations with reputable research institutions in Singapore.
  • - Read this at SGinvestors.io -
  • - Read this at SGinvestors.io -
  • Hyphens Pharma products are selling in the premium market while Novem are targeting mostly the public sector. Prior to Novem acquisition, ~42% of sales are from the government. With the Healthier SG scheme, the public sector will grow at a faster pace, benefitting the Hyphens Pharma from the acquisition where ~60% of Novem sales are to government hospitals and polyclinics.

Hyphens Pharma – Investment Thesis


  • Read more at SGinvestors.io.

Yeo Peng Joon SAC Capital Research | Matthias Chan SAC Capital | https://www.saccapital.com.sg/ 2023-05-25

Read also SAC's most recent report:
2024-03-26 Hyphens Pharma International - What A Difference A Half Makes.

Previous report by SAC:
2023-11-20 Hyphens Pharma International - 3Q23 Business Update.

Price targets by 2 other brokers at Hyphens Pharma Target Prices.

Listing of research reports at Hyphens Pharma Analyst Reports.

Relevant links:
Hyphens Pharma Share Price History,
Hyphens Pharma Announcements,
Hyphens Pharma Dividends & Corporate Actions,
Hyphens Pharma News Articles


You May Also Like

SGX Stock / REIT Search


Most Read

Trust Bank God Of Fortune Referral Code PGKPSWAE Trust Bank Referral Code 🎁